Schizophrenia Overview

Foundational guides to understanding schizophrenia, psychosis, and how the condition affects daily life.

Schizophrenia Overview Psychosis & Episodes Medications Side Effects Famous People with Schizophrenia Patient Experiences CBT for Psychosis Hospitalisation & Crisis Lifestyle & Wellbeing For Families & Caregivers Engineering

What causes schizophrenia? An evidence-based answer

There is no single cause of schizophrenia. The current consensus is that genes load the gun, and environment — pregnancy, adolescent stress, heavy cannabis use — sometimes pulls the trigger.

A short history of schizophrenia: from Kraepelin to today

Schizophrenia is barely 130 years old as a concept. Tracing its history — through Kraepelin, Bleuler, Schneider, and the antipsychotic era — explains a lot about why the diagnosis still feels unsettled.

Is schizophrenia genetic? What twin and family studies show

Schizophrenia is highly heritable — about 80% — but no single gene causes it. Identical twins of people with schizophrenia have a 40–50% chance of developing it themselves.

Schizophrenia vs bipolar disorder with psychotic features

Both conditions can involve hallucinations and delusions, but the relationship between mood and psychosis is the key difference. Here's what clinicians actually look at.

Geriatric schizophrenia: an overview

Schizophrenia doesn't end at 55. As the population ages, more people are living into their 70s and 80s with the condition — and care has to change with them.

Childhood-onset schizophrenia (COS): a deeper look

Childhood-onset schizophrenia (COS) — schizophrenia that begins before age 13 — is rare, severe, and intensively studied at the NIMH. Diagnosis is careful and treatment is multi-layered.

Myth: Schizophrenia means multiple personalities

One of the most persistent misconceptions about schizophrenia is that it means having multiple personalities. It doesn't — and the difference matters.

The dopamine hypothesis of schizophrenia: history and revisions

The dopamine hypothesis is the oldest and most influential biological theory of schizophrenia. Seventy years in, it explains a lot — but not everything.

Is schizophrenia a disability under US law?

Schizophrenia qualifies as a disability under federal civil rights law and Social Security disability programs. The protections you're entitled to depend on which law applies.

Schizophrenia and ADHD: overlap, differences, and treatment cautions

Both conditions can involve poor attention and executive dysfunction, but the underlying mechanisms — and treatments — are very different. Stimulants need careful thought in psychosis.

Myth: People with schizophrenia are violent

The stereotype of the 'dangerous schizophrenic' is one of the most damaging myths in mental health. The data tell a very different story.

The glutamate (NMDA) hypothesis of schizophrenia

Dopamine has dominated schizophrenia research for decades, but glutamate — the brain's main excitatory neurotransmitter — may be closer to the underlying problem.

How schizophrenia is diagnosed: the clinical interview

Schizophrenia is diagnosed by a clinician sitting down with you for a long, structured conversation. Here is what that interview covers and why each piece matters.

Late-onset schizophrenia: when the first episode happens after 40-50

About 15-20% of schizophrenia cases first appear after age 40. The presentation, prognosis, and medication response often differ from typical early-onset schizophrenia.

Adolescent-onset schizophrenia: a critical window

When schizophrenia first appears in adolescence, the year or two after onset shapes the rest of the illness. Early, organised treatment can change the trajectory.

Clinical High Risk (CHR) for psychosis: what it means and what it doesn't

The Clinical High Risk (CHR) category identifies young people whose symptoms may evolve into a psychotic disorder. Most don't — and that nuance matters enormously.

Schizophrenia statistics: prevalence, age of onset, demographics

Schizophrenia is rarer than most people assume but more universal in its global distribution than almost any other illness. The numbers worth knowing — and what they actually mean.

Can schizophrenia be cured? What recovery actually means

Schizophrenia cannot be cured in the way an infection can be cured, but it can be treated effectively, and a substantial proportion of people achieve long-term recovery.

Schizophrenia and OCD: overlap, distinctions, and shared treatment

Around a quarter of people with schizophrenia also meet criteria for OCD. The line between an obsession and a delusion can be subtle but matters for treatment.

Myth: Bad parenting causes schizophrenia

The idea that parents — especially mothers — cause schizophrenia did enormous harm to families for decades. Modern research tells a very different story.

Serotonin (5-HT2A) and atypical antipsychotics

Adding serotonin 5-HT2A blockade to dopamine blockade gave us the 'atypical' antipsychotics. Here is what serotonin actually does in this story.

DSM-5 criteria for schizophrenia, explained plainly

The DSM-5-TR criteria for schizophrenia are precise but readable. Here is what each one actually means, in plain language, with the clinical reasoning behind it.

Can we prevent a first episode of psychosis? An honest look

Genuine prevention of psychosis is harder than it sounds — but several modest interventions appear to delay onset or reduce severity. Here is the honest picture.

How long does schizophrenia last?

Schizophrenia is generally considered a lifelong condition, but the course is variable: some people have a single episode, others have recurrent episodes, and a smaller group has a chronic course.

Schizophrenia and eating disorders: a complex overlap

Eating disorders in schizophrenia are often missed — sometimes because food-related delusions are mistaken for anorexia, sometimes because antipsychotic-driven binge eating is dismissed as 'just side effects.'

Very-late-onset schizophrenia-like psychosis (after 60)

First-episode psychosis after 60 has its own name — very-late-onset schizophrenia-like psychosis — and a presentation that's distinct from both classic schizophrenia and dementia.

Very-early-onset schizophrenia (under age 13)

Very-early-onset schizophrenia (VEOS) is rare, often misdiagnosed at first, and demands a careful, multidisciplinary work-up before any diagnosis is made.

Myth: You can't recover from schizophrenia

Decades of long-term research show that recovery from schizophrenia is real and common — even though clinicians and the public often assume otherwise.

Why Black Americans are over-diagnosed with schizophrenia

Black Americans are diagnosed with schizophrenia at three to four times the rate of white Americans — a gap driven less by biology than by clinician bias, structural racism, and how symptoms get heard.

Schizophrenia care in the UK NHS: EIP, CMHTs, and the CPA

The NHS care pathway for schizophrenia is built around early intervention teams, community mental health teams, and structured care planning — here's how it actually works.

Schizophrenia in women: onset, hormones, pregnancy, outcomes

Schizophrenia affects men and women at similar rates over a lifetime, but the timing, hormonal interactions, and life-stage challenges look very different. A practical overview for women and their clinicians.

NMDA receptor hypofunction in schizophrenia

NMDA receptor hypofunction is one of the most testable and best-supported neuroscience models of schizophrenia — and one of the hardest to translate into new drugs.

ICD-11 vs DSM-5: how schizophrenia is classified globally

American psychiatrists use the DSM-5-TR. Most of the rest of the world uses the WHO's ICD-11. Both define schizophrenia — but they emphasise different things.

How is schizophrenia diagnosed? The DSM-5-TR criteria explained

Schizophrenia is diagnosed by a psychiatrist or qualified clinician using the DSM-5-TR or ICD-11 criteria. There is no blood test or brain scan — the diagnosis is clinical.

Schizophrenia vs borderline personality disorder

Up to 30% of people with borderline personality disorder report brief psychotic-like experiences, which can lead to misdiagnosis. Here's what actually separates the two conditions.

Myth: People with schizophrenia can't hold a job

The assumption that schizophrenia rules out employment is wrong. Evidence-based supported employment helps the majority of participants find competitive work.

Genetic counseling for schizophrenia: what families should know

Psychiatric genetic counseling helps families understand inherited risk for schizophrenia honestly — without overpromising or fuelling unnecessary fear.

Dementia vs late-onset psychosis: telling them apart

An older adult with new hallucinations or delusions might have late-onset schizophrenia, a dementia syndrome, delirium, or a medical condition. Sorting it out matters enormously for treatment.

Antipsychotics in adolescents: what families need to know

Several antipsychotics are FDA-approved for adolescents with schizophrenia. Choosing one is a careful, family-centred conversation about benefits, side effects, and monitoring.

Latino communities and schizophrenia care access

Latino Americans with schizophrenia are less likely to be diagnosed early, less likely to receive specialist care, and more likely to face language and immigration barriers — even when insurance is available.

Schizophrenia care in Canada: EPI programs and provincial variability

Canada's universal health system covers schizophrenia treatment, but services vary widely by province. Here's how Early Psychosis Intervention programs and other supports actually work.

Schizophrenia in men: earlier onset, harder course, the data

Men with schizophrenia are typically diagnosed earlier than women and face a slightly more difficult average course. The reasons are not fully understood — but the patterns matter for how care is organised.

What are the early signs of schizophrenia?

Early signs of schizophrenia include social withdrawal, declining performance, sleep changes, and unusual perceptual experiences — usually appearing in the late teens or early twenties.

Schizophrenia vs autism spectrum: overlap and distinctions

Autism and schizophrenia share social withdrawal and unusual perceptions but are distinct neurodevelopmental and psychotic conditions — and they can co-occur in the same person.

Myth: Schizophrenia means low intelligence

Schizophrenia changes how the brain processes information, but it does not reduce a person's underlying intelligence. The relationship is more complex than the stereotype.

Neuroinflammation in schizophrenia: cytokines, microglia, complement

Schizophrenia increasingly looks like a disorder with an immune component. Microglia, complement proteins, and cytokines are now central to research — though many questions remain.

The PANSS (Positive and Negative Syndrome Scale) explained

The PANSS is the rating scale you will see in nearly every schizophrenia drug trial. Here is what each of its 30 items measures and how to read PANSS results in research papers.

The McGorry omega-3 prevention trial: what happened next

A 2010 fish-oil trial suggested omega-3s could prevent psychosis in at-risk young people. A larger replication failed. Here is what the science actually shows now.

Schizophrenia and PTSD: shared symptoms, separate diagnoses

Trauma is common in people with schizophrenia, and PTSD symptoms can mimic — or amplify — psychotic ones. The two conditions need to be addressed together.

Antipsychotics in older adults: dose, monitoring, and the FDA box warning

Antipsychotics in older adults work — but dosing, monitoring, and indication all have to change. The Beers Criteria and FDA boxed warning shape every prescribing decision.

Myth: People with schizophrenia shouldn't have children

The blanket idea that people with schizophrenia shouldn't have children carries echoes of eugenics and is not supported by modern evidence on parenting or genetics.

Asian American communities, schizophrenia, and family stigma

Asian American adults use mental health services at the lowest rate of any major US racial group. The gap is not about lower need — it is about stigma, family expectation, and a workforce that rarely matches the patient.

Schizophrenia care in Australia: headspace, EPPIC, and Medicare

Australia pioneered early intervention in psychosis through EPPIC, built the world's largest youth mental health network in headspace, and funds psychology through Medicare. Here's how the system fits together.

Late-onset schizophrenia: when psychosis emerges after 40

Schizophrenia can begin after 40 — and even after 60. These late-onset presentations are different from textbook young-adult cases and are easily missed. A practical overview.

What's the best medication for schizophrenia? An honest answer

There is no single best antipsychotic for everyone. Clozapine is the most effective overall but is reserved for treatment-resistant cases due to monitoring requirements. The right medication depends on individual response and side-effect tolerability.

Neural oscillations (gamma, theta) in schizophrenia

Brain rhythms coordinate the orchestra of cognition. In schizophrenia, gamma and theta oscillations are altered in ways that link parvalbumin interneuron dysfunction to symptoms.

School accommodations for a teen with schizophrenia

Adolescents with schizophrenia often need real changes to how school works — quieter spaces, flexible deadlines, reduced course loads. Most of these are protected under federal law.

The gut-brain axis in schizophrenia

The gut-brain axis is one of the most intriguing frontiers in schizophrenia research — and one of the most overhyped. Here is what is solid and what is still speculative.

The Brief Psychiatric Rating Scale (BPRS) explained

The BPRS is shorter and older than the PANSS but still widely used. Here is what each of its 18 items captures and how to read BPRS results in your clinic notes.

What is schizophrenia? A plain-language guide

Schizophrenia is a chronic brain condition that affects how a person thinks, feels, and perceives reality — but it is treatable, and recovery is real.

Early warning signs of schizophrenia: what to watch for

The early warning signs of schizophrenia — the prodrome — often appear months or even years before a first full episode. Recognising them early dramatically improves long-term outcomes.

Schizophrenia vs Cluster A personality disorders

The three Cluster A personality disorders all bear a family resemblance to schizophrenia. Telling them apart from each other and from schizophrenia is a routine but important task.

Brain volume changes in schizophrenia: what the imaging shows

Structural MRI studies in schizophrenia consistently show modest reductions in cortical and hippocampal volume and modest enlargement of the ventricles — but the picture for any individual is more nuanced.

Schizophrenia and anxiety disorders: a guide to common overlap

More than half of people with schizophrenia also meet criteria for at least one anxiety disorder. Treating anxiety can dramatically improve quality of life — but it's often missed.

Polypharmacy in elderly patients with schizophrenia

Older adults with schizophrenia commonly take 8 or more medications. Each one adds risk. A structured medication review is one of the most important tools in geriatric psychiatry.

Schizophrenia care in India: the District Mental Health Programme

India has one of the world's largest populations living with schizophrenia. The system relies on the District Mental Health Programme, charitable hospitals, and the irreplaceable role of family caregivers.

Childhood-onset schizophrenia: a rare and severe variant

Schizophrenia before age 13 is rare — fewer than 1 in 30,000 children — but profoundly serious. It overlaps with autism and other neurodevelopmental conditions and demands specialist care.

Positive vs negative symptoms of schizophrenia

Positive symptoms add things to a person's experience (voices, beliefs). Negative symptoms take things away (motivation, emotion, speech). Both deserve attention.

Schizophrenia self-test: what online quizzes can and can't tell you

Online schizophrenia self-tests cannot diagnose you. They can flag whether your concerns are worth bringing to a clinician, but actual diagnosis requires a comprehensive psychiatric evaluation.

IEPs and 504 plans for students with schizophrenia

An IEP and a 504 plan are different legal tools that help students with disabilities. Here's how to choose between them when schizophrenia is in the picture.

Myth: Antipsychotics turn people into zombies

The 'medication zombie' image comes from old, high-dose typical antipsychotics. Modern prescribing aims for the lowest effective dose — and most people on it do not feel flat.

Indigenous communities and schizophrenia care

Indigenous communities in the US carry a disproportionate burden of trauma, suicide, and serious mental illness — and the federal system meant to provide their care has been chronically underfunded for generations.

Mismatch negativity (MMN): a candidate biomarker for schizophrenia

Mismatch negativity is one of the most reliable biological abnormalities ever found in schizophrenia — and a window into NMDA receptor function in the living brain.

Coordinated Specialty Care (CSC): the team-based model for first-episode psychosis

Coordinated Specialty Care brings a multidisciplinary team around young people in their first episode of psychosis. It is now the standard of care in much of the US.

The SCID interview: what to expect

The SCID-5 is the structured interview used in research and difficult clinical cases to confirm a DSM-5 diagnosis. Here is what it looks like and how to prepare.

Schizophrenia vs schizoaffective disorder: what's the difference?

Schizoaffective disorder sits at the intersection of schizophrenia and a mood disorder (depression or bipolar). The diagnostic difference matters for treatment.

Soteria House: the medication-minimal community model

Soteria House was a small residential alternative to acute psychiatric care, pioneered in California in the 1970s. Its quiet, low-medication, peer-based model still informs modern psychosis services.

Schizophrenia myths and facts: ten things people still get wrong

Most of what people believe about schizophrenia is wrong, exaggerated, or out of date. Ten of the most persistent myths — corrected with sources, calmly.

Schizotypal vs schizoid vs schizophrenia

Three diagnoses share the 'schiz-' prefix but describe very different lives. Here is what schizotypal, schizoid, and schizophrenia actually mean.

White matter changes in schizophrenia

Diffusion MRI studies show widespread reductions in white matter integrity in schizophrenia, with the largest effects in the corpus callosum and frontotemporal tracts.

MRS (magnetic resonance spectroscopy) in schizophrenia

MR spectroscopy uses the same scanner as MRI to measure brain chemistry directly. In schizophrenia, it has produced some of the strongest non-PET evidence on glutamate, GABA, and energy metabolism.

Schizoaffective disorder vs schizophrenia: a deeper look

Schizoaffective disorder is the diagnostic middle ground between schizophrenia and primary mood disorders — and it's one of the most complicated calls in psychiatry.

Fall risk on antipsychotics in older adults

Falls are the leading cause of injury death in older adults — and antipsychotics are one of the strongest medication-related risk factors. Here's what to do.

LGBTQ+ people with schizophrenia: a deeper look at gaps in care

LGBTQ+ people with schizophrenia carry the combined weight of two heavily stigmatised identities. Recent research is finally describing the specific gaps — and what gender-affirming, trauma-informed psychiatric care looks like.

P50 sensory gating in schizophrenia

P50 sensory gating measures how the brain filters repeated sounds. People with schizophrenia gate poorly — and that finding has shaped decades of research.

The RAISE trial: how it changed first-episode care in the US

RAISE was the largest US trial ever of first-episode psychosis care. Its findings reshaped how the country pays for and delivers early intervention.

Schizophrenia symptoms in adults

Adult schizophrenia symptoms fall into three groups: positive (hallucinations, delusions), negative (reduced motivation and emotion), and cognitive (attention and memory difficulties). Most people experience some from each group.

When you notice prodromal symptoms in your teen

Many parents notice the first signs of trouble months before anyone gets a diagnosis. What you do in those months matters.

Myth: Schizophrenia is purely genetic

Genetics matter in schizophrenia, but they are not destiny. Environmental, developmental, and lifestyle factors all play measurable roles.

Differential diagnosis: schizophrenia vs bipolar, drugs, autism, OCD, PTSD

Schizophrenia is one diagnosis among many that can produce overlapping symptoms. Here is how clinicians sort schizophrenia from bipolar disorder, drug-induced psychosis, autism, OCD, and PTSD.

The Trieste model: deinstitutionalisation done differently

When Franco Basaglia closed the asylum in Trieste, he replaced it with 24-hour community mental health centres. Fifty years on, the Trieste model is still studied as a benchmark for community psychiatry.

Schizophrenia and creativity: what the evidence actually shows

The 'mad genius' idea is older than psychiatry. The actual research on schizophrenia and creativity is more interesting — and more nuanced — than either the romantic or the dismissive version suggests.

Prepulse inhibition (PPI) in schizophrenia research

Prepulse inhibition tests how a small warning sound dampens the startle response. People with schizophrenia show less of this dampening — a finding that has shaped decades of research.

PET imaging in schizophrenia: dopamine and beyond

PET imaging measures neurotransmitter activity directly in the living brain. It has provided some of the strongest evidence for the dopamine hypothesis — and now points to glutamate and inflammation as well.

Schizophrenia symptoms in women: what's different

Schizophrenia in women tends to begin later than in men, often involves more mood symptoms, and is influenced by hormonal cycles. There is also a second onset peak around menopause.

The salience network in schizophrenia

The salience network helps the brain decide what deserves attention and switches between internally and externally focused modes. In schizophrenia, both functions appear disrupted.

Myth: Schizophrenia is a rare disease

Schizophrenia is often described as 'rare,' but the WHO estimates roughly 24 million people worldwide live with it — a public health issue of substantial scale.

Immigrants and schizophrenia: language, documentation, trauma

First-generation immigrants and their children carry an elevated risk of psychosis — and also a more complex path through any health system. Language, documentation, and trauma all shape what schizophrenia care looks like.

The WHO Comprehensive Mental Health Action Plan

The WHO Comprehensive Mental Health Action Plan 2013–2030 is the closest thing the world has to a global blueprint for community-based, rights-respecting mental health care. Here's what it says and where progress stands.

Early intervention services for psychosis: international models

Early intervention services for psychosis began in Australia in the 1990s and now exist worldwide. Here is what the leading international models look like.

Getting a second opinion on a schizophrenia diagnosis

Schizophrenia is one of the highest-stakes diagnoses in medicine — and not always the right one. Here is when a second opinion is reasonable and how to actually get one.

Schizophrenia across cultures: different countries, different outcomes

Schizophrenia exists everywhere humans live, but its long-term course is not identical across cultures. The WHO international studies gave us some of psychiatry's most important — and contested — cross-cultural findings.

Schizoaffective vs schizophrenia vs bipolar

Three diagnoses, one diagnostic question: how do mood symptoms and psychotic symptoms relate to each other over time? The answer points to schizoaffective, schizophrenia, or bipolar.

Coordinated Specialty Care (CSC) for first-episode youth

Coordinated Specialty Care (CSC) is a team-based, evidence-supported model for first-episode psychosis. For young people, it dramatically improves outcomes.

fMRI research in schizophrenia

Functional MRI lets researchers watch the brain at work. In schizophrenia, two decades of fMRI studies have changed how we think about brain networks — but it is still not a diagnostic test.

Rural schizophrenia care: distance, telehealth, and gaps

Most US counties have no practising psychiatrist. For rural Americans with schizophrenia, the work of getting care is often the work of bridging miles, broadband gaps, and a workforce shortage that is decades deep.

The global burden of schizophrenia: prevalence and DALYs

Schizophrenia affects about 24 million people worldwide and contributes a disproportionate share of years lived with disability. Here's what the global numbers tell us — and what they don't.

The genetic risk of schizophrenia: what we know in 2026

Schizophrenia is highly heritable — but no single gene 'causes' it. A clear-eyed look at the genetic evidence as it stands in 2026, and what it does and doesn't mean for families.

The default mode network in schizophrenia

The default mode network is the brain's self-referential, mind-wandering circuit. In schizophrenia, it shows hyperconnectivity at rest and fails to deactivate during tasks, contributing to symptoms.

Brain imaging in schizophrenia: what MRI and PET show — and what they don't

MRI and PET scans show real differences between groups of people with and without schizophrenia, but they cannot diagnose any individual. Here is what imaging can and cannot do.

Schizophrenia vs dementia in older adults

Psychosis in an older adult can be late-onset schizophrenia, a dementia, delirium, or several other conditions. The differences guide treatment.

Schizophrenia symptoms in men: what's different

Schizophrenia in men typically begins in the late teens or early twenties, with more prominent negative symptoms and higher rates of substance use than in women. Treatment principles are similar, but presentation differs.

Brief psychotic disorder: a focused guide

Brief psychotic disorder is a short, often dramatic episode of psychosis that fully resolves within a month. It's distinct from schizophrenia and usually has a much better prognosis.

Brain volume changes in schizophrenia: what MRI studies show

MRI studies have shown small but consistent brain volume differences in schizophrenia. The findings are real — but interpreting them honestly is more nuanced than the headlines suggest.

Duration of untreated psychosis (DUP): why earlier is better

Duration of untreated psychosis (DUP) is one of the most consistent predictors of long-term outcome in schizophrenia. Reducing it is one of the field's clearest goals.

Urban schizophrenia care: density, fragmentation, ED reliance

Cities have more psychiatrists per capita — and also more fragmented care, more emergency-department reliance, and worse outcomes for many of the most vulnerable patients. Density does not automatically equal access.

The striatum in schizophrenia

Decades of PET imaging have shown elevated presynaptic dopamine in the striatum of people with schizophrenia. The associative striatum, not the limbic striatum, is where the abnormality is largest.

Copy number variants (CNVs) in schizophrenia

Copy number variants are larger structural changes in DNA — duplications or deletions of whole gene-containing segments. A handful are now established as strong, rare risk factors for schizophrenia.

Gender disparities in schizophrenia: diagnosis and outcomes

Schizophrenia is not a one-shape illness. Onset, course, treatment response, and side-effect risk all differ between men and women — and ignoring these differences leaves both groups under-served.

Neuropsychological testing in schizophrenia

Neuropsychological testing measures the cognitive strengths and weaknesses of schizophrenia in detail — useful for treatment planning, school accommodations, and tracking change.

The prefrontal cortex in schizophrenia

The prefrontal cortex underlies the cognitive symptoms of schizophrenia. Reduced volume, lower activation during effortful tasks, and altered GABA interneuron function are among the most consistent findings.

22q11.2 deletion syndrome and schizophrenia

Roughly one in four people with 22q11.2 deletion syndrome develops schizophrenia or a related psychotic disorder. The condition is the strongest single genetic risk factor for schizophrenia known.

Religious minorities and schizophrenia care

Religious belief is woven through how many patients with schizophrenia experience and explain their illness. For minority faith communities, mainstream psychiatry often misses both the strength and the specificity.

Nursing home care for adults with schizophrenia

Long-term care for older adults with schizophrenia is one of the hardest navigation challenges in mental health. Here's what families and clinicians need to understand about the system.

The thalamus in schizophrenia

The thalamus relays nearly every sensory and cortical signal in the brain. In schizophrenia, parts of the thalamus shrink, its connections rewire, and signals between thalamus and cortex become less coordinated.

Polygenic risk scores for schizophrenia: what they can and can't tell you

Polygenic risk scores compress hundreds of small-effect schizophrenia variants into a single number. Useful in research, not yet ready for the clinic.

Schizophrenia vs DID: clearing up the confusion

The 'split mind' translation of schizophrenia has fuelled a century of confusion with dissociative identity disorder. Here is what actually separates the two conditions.

Schizophrenia vs psychopathy: not the same thing

Schizophrenia and psychopathy get blurred together in headlines and movies, but they are different conditions in different chapters of the diagnostic manual. Here is what each one actually is.

The hippocampus in schizophrenia

The hippocampus is one of the most consistently affected brain regions in schizophrenia. Smaller volumes, regional hyperactivity, and CA1 dysfunction appear early and may help drive dopamine abnormalities downstream.

Schizophrenia GWAS: what genome-wide association studies have found

Genome-wide association studies have identified hundreds of genetic loci linked to schizophrenia. Here is what those findings mean — and what they still cannot tell us.